Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease

BACKGROUND: Butyrate-producing gut bacteria are reduced in patients with active inflammatory bowel disease (IBD), supporting the hypothesis that butyrate supplementation may be beneficial in this setting. Nonetheless, earlier studies suggest that the oxidation of butyrate in IBD patients is altered....

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrer-Picón, Elena, Dotti, Isabella, Corraliza, Ana M, Mayorgas, Aida, Esteller, Miriam, Perales, José Carlos, Ricart, Elena, Masamunt, Maria C, Carrasco, Anna, Tristán, Eva, Esteve, Maria, Salas, Azucena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Basic Science Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905302/
https://www.ncbi.nlm.nih.gov/pubmed/31211831
http://dx.doi.org/10.1093/ibd/izz119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905302/
https://www.ncbi.nlm.nih.gov/pubmed/31211831
http://dx.doi.org/10.1093/ibd/izz119

Ejemplares similares